EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, is now recruiting
Cure Parkinson’s is excited to announce that the first multi-arm multi-stage clinical trial platform for Parkinson’s in the UK – EJS ACT-PD – is underway, with recruitment now open to people with Parkinson’s. The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD)...
Learn moreCure Parkinson’s Fundraising Heroes: August 2025
From walking and running, to afternoon tea and a duck race, take a look at how some of our Fundraising Heroes supported us in August. Dover to Deal Longtime Cure Parkinson’s supporter Theresa organised her own Walk To Cure Parkinson’s trek. Embarking on a stretch…
Dr Matthew Farrer wins 2025 Tom Isaacs Award
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Matthew Farrer as the winner of the 2025 Tom Isaacs Award, which honours researchers who closely collaborate with the Parkinson’s community. The two organisations were delighted to announce Dr Matthew Farrer as winner…
October Walking Challenge 2025!
We’re thrilled to announce that our October Walking Challenge is back by popular demand for 2025! Walk 100km across the month to raise funds for Cure Parkinson’s. We’re here for the cure and your support helps fund vital research projects with the potential to slow,...
Combination therapies: a change in approach for Parkinson’s research
As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting Parkinson’s progression. Currently, clinical trials of potentially disease-modifying therapies for Parkinson’s are largely focussed on testing single drugs, or monotherapies. These drugs often…
Press Release: Cure Parkinson’s paves the way for combination therapies by announcing a £2m funding call
In June, Cure Parkinson’s convened a workshop of researchers, organisations and individuals in the Parkinson’s community to focus on developing combination therapies. This informed the £2m funding call that we are announcing today that will open in October 2025. Currently, clinical trials for Parkinson’s have…